Selected research
Market Structure
Global Immune Cell Storage Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Immune Cell Storage Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Immune Cell Storage Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Immune Cell Storage Service include HealthBanks, BioLife Solutions, Sartorius, ThermoGenesis, Charles River, Biorep Technologies, Cryo-Cell International, CGT GLOBAL and Cordlife Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Immune Cell Storage Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Immune Cell Storage Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Immune Cell Storage Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Immune Cell Storage Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Immune Cell Storage Service Segment by Company
HealthBanks
BioLife Solutions
Sartorius
ThermoGenesis
Charles River
Biorep Technologies
Cryo-Cell International
CGT GLOBAL
Cordlife Group
Celularity
Boyalife
Beike Biotechnology
Forever Labs
Redermis
LifeCell International
VCANBIO
BGI Group
Shanghai Cell Therapy Group
Immune Cell Storage Service Segment by Type
Neonatal Immune Cell Storage
Adult Immune Cell Storage
Immune Cell Storage Service Segment by Application
Medical Scene
Non-medical Scene
Immune Cell Storage Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Cell Storage Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immune Cell Storage Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Cell Storage Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Immune Cell Storage Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immune Cell Storage Service industry.
Chapter 3: Detailed analysis of Immune Cell Storage Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune Cell Storage Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Neonatal Immune Cell Storage
- Adult Immune Cell Storage
Applications
- Medical Scene
- Non-medical Scene
Companies covered
- HealthBanks
- BioLife Solutions
- Sartorius
- ThermoGenesis
- Charles River
- Biorep Technologies
- Cryo-Cell International
- CGT GLOBAL
- Cordlife Group
- Celularity
- Boyalife
- Beike Biotechnology
- Forever Labs
- Redermis
- LifeCell International
- VCANBIO
- BGI Group
- Shanghai Cell Therapy Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Immune Cell Storage Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Neonatal Immune Cell Storage
- 1.2.3 Adult Immune Cell Storage
- 1.3 Market Analysis by Application
- 1.3.1 Global Immune Cell Storage Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Medical Scene
- 1.3.3 Non-medical Scene
- 1.4 Global Market Growth Prospects
- 1.5 Global Immune Cell Storage Service Growth Trends by Region
- 1.5.1 Global Immune Cell Storage Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Immune Cell Storage Service Market Size by Region (2021-2026)
- 1.5.3 Immune Cell Storage Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Immune Cell Storage Service Market Dynamics
- 2.1 Immune Cell Storage Service Industry Trends
- 2.2 Immune Cell Storage Service Industry Drivers
- 2.3 Immune Cell Storage Service Industry Opportunities and Challenges
- 2.4 Immune Cell Storage Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Immune Cell Storage Service Revenue by Company (2021-2026)
- 3.2 Global Immune Cell Storage Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Immune Cell Storage Service Key Company Head office and Area Served
- 3.4 Global Immune Cell Storage Service Company, Product Type & Application
- 3.5 Global Immune Cell Storage Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Immune Cell Storage Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Immune Cell Storage Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Immune Cell Storage Service Tier 1, Tier 2, and Tier 3
4 Immune Cell Storage Service Market by Type
- 4.1 Global Immune Cell Storage Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Immune Cell Storage Service Market Size by Type (2021-2032)
- 4.3 Global Immune Cell Storage Service Market Size Share by Type (2021-2032)
5 Immune Cell Storage Service Market by Application
- 5.1 Global Immune Cell Storage Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Immune Cell Storage Service Market Size by Application (2021-2032)
- 5.3 Global Immune Cell Storage Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 HealthBanks
- 6.1.1 HealthBanks Company Information
- 6.1.2 HealthBanks Business Overview
- 6.1.3 HealthBanks Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 HealthBanks Immune Cell Storage Service Product Portfolio
- 6.1.5 HealthBanks Recent Developments
- 6.2 BioLife Solutions
- 6.2.1 BioLife Solutions Company Information
- 6.2.2 BioLife Solutions Business Overview
- 6.2.3 BioLife Solutions Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 BioLife Solutions Immune Cell Storage Service Product Portfolio
- 6.2.5 BioLife Solutions Recent Developments
- 6.3 Sartorius
- 6.3.1 Sartorius Company Information
- 6.3.2 Sartorius Business Overview
- 6.3.3 Sartorius Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Sartorius Immune Cell Storage Service Product Portfolio
- 6.3.5 Sartorius Recent Developments
- 6.4 ThermoGenesis
- 6.4.1 ThermoGenesis Company Information
- 6.4.2 ThermoGenesis Business Overview
- 6.4.3 ThermoGenesis Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 ThermoGenesis Immune Cell Storage Service Product Portfolio
- 6.4.5 ThermoGenesis Recent Developments
- 6.5 Charles River
- 6.5.1 Charles River Company Information
- 6.5.2 Charles River Business Overview
- 6.5.3 Charles River Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Charles River Immune Cell Storage Service Product Portfolio
- 6.5.5 Charles River Recent Developments
- 6.6 Biorep Technologies
- 6.6.1 Biorep Technologies Company Information
- 6.6.2 Biorep Technologies Business Overview
- 6.6.3 Biorep Technologies Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Biorep Technologies Immune Cell Storage Service Product Portfolio
- 6.6.5 Biorep Technologies Recent Developments
- 6.7 Cryo-Cell International
- 6.7.1 Cryo-Cell International Company Information
- 6.7.2 Cryo-Cell International Business Overview
- 6.7.3 Cryo-Cell International Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Cryo-Cell International Immune Cell Storage Service Product Portfolio
- 6.7.5 Cryo-Cell International Recent Developments
- 6.8 CGT GLOBAL
- 6.8.1 CGT GLOBAL Company Information
- 6.8.2 CGT GLOBAL Business Overview
- 6.8.3 CGT GLOBAL Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 CGT GLOBAL Immune Cell Storage Service Product Portfolio
- 6.8.5 CGT GLOBAL Recent Developments
- 6.9 Cordlife Group
- 6.9.1 Cordlife Group Company Information
- 6.9.2 Cordlife Group Business Overview
- 6.9.3 Cordlife Group Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Cordlife Group Immune Cell Storage Service Product Portfolio
- 6.9.5 Cordlife Group Recent Developments
- 6.10 Celularity
- 6.10.1 Celularity Company Information
- 6.10.2 Celularity Business Overview
- 6.10.3 Celularity Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Celularity Immune Cell Storage Service Product Portfolio
- 6.10.5 Celularity Recent Developments
- 6.11 Boyalife
- 6.11.1 Boyalife Company Information
- 6.11.2 Boyalife Business Overview
- 6.11.3 Boyalife Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Boyalife Immune Cell Storage Service Product Portfolio
- 6.11.5 Boyalife Recent Developments
- 6.12 Beike Biotechnology
- 6.12.1 Beike Biotechnology Company Information
- 6.12.2 Beike Biotechnology Business Overview
- 6.12.3 Beike Biotechnology Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Beike Biotechnology Immune Cell Storage Service Product Portfolio
- 6.12.5 Beike Biotechnology Recent Developments
- 6.13 Forever Labs
- 6.13.1 Forever Labs Company Information
- 6.13.2 Forever Labs Business Overview
- 6.13.3 Forever Labs Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Forever Labs Immune Cell Storage Service Product Portfolio
- 6.13.5 Forever Labs Recent Developments
- 6.14 Redermis
- 6.14.1 Redermis Company Information
- 6.14.2 Redermis Business Overview
- 6.14.3 Redermis Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Redermis Immune Cell Storage Service Product Portfolio
- 6.14.5 Redermis Recent Developments
- 6.15 LifeCell International
- 6.15.1 LifeCell International Company Information
- 6.15.2 LifeCell International Business Overview
- 6.15.3 LifeCell International Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 LifeCell International Immune Cell Storage Service Product Portfolio
- 6.15.5 LifeCell International Recent Developments
- 6.16 VCANBIO
- 6.16.1 VCANBIO Company Information
- 6.16.2 VCANBIO Business Overview
- 6.16.3 VCANBIO Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 VCANBIO Immune Cell Storage Service Product Portfolio
- 6.16.5 VCANBIO Recent Developments
- 6.17 BGI Group
- 6.17.1 BGI Group Company Information
- 6.17.2 BGI Group Business Overview
- 6.17.3 BGI Group Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 BGI Group Immune Cell Storage Service Product Portfolio
- 6.17.5 BGI Group Recent Developments
- 6.18 Shanghai Cell Therapy Group
- 6.18.1 Shanghai Cell Therapy Group Company Information
- 6.18.2 Shanghai Cell Therapy Group Business Overview
- 6.18.3 Shanghai Cell Therapy Group Immune Cell Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Shanghai Cell Therapy Group Immune Cell Storage Service Product Portfolio
- 6.18.5 Shanghai Cell Therapy Group Recent Developments
7 North America
- 7.1 North America Immune Cell Storage Service Market Size (2021-2032)
- 7.2 North America Immune Cell Storage Service Market Size by Type
- 7.2.1 North America Immune Cell Storage Service Market Size by Type (2021-2026)
- 7.2.2 North America Immune Cell Storage Service Market Size by Type (2027-2032)
- 7.2.3 North America Immune Cell Storage Service Market Share by Type (2021-2032)
- 7.3 North America Immune Cell Storage Service Market Size by Application
- 7.3.1 North America Immune Cell Storage Service Market Size by Application (2021-2026)
- 7.3.2 North America Immune Cell Storage Service Market Size by Application (2027-2032)
- 7.3.3 North America Immune Cell Storage Service Market Share by Application (2021-2032)
- 7.4 North America Immune Cell Storage Service Market Size by Country
- 7.4.1 North America Immune Cell Storage Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Immune Cell Storage Service Market Size by Country (2021-2026)
- 7.4.3 North America Immune Cell Storage Service Market Size by Country (2027-2032)
- 7.4.4 North America Immune Cell Storage Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Immune Cell Storage Service Market Size (2021-2032)
- 8.2 Europe Immune Cell Storage Service Market Size by Type
- 8.2.1 Europe Immune Cell Storage Service Market Size by Type (2021-2026)
- 8.2.2 Europe Immune Cell Storage Service Market Size by Type (2027-2032)
- 8.2.3 Europe Immune Cell Storage Service Market Share by Type (2021-2032)
- 8.3 Europe Immune Cell Storage Service Market Size by Application
- 8.3.1 Europe Immune Cell Storage Service Market Size by Application (2021-2026)
- 8.3.2 Europe Immune Cell Storage Service Market Size by Application (2027-2032)
- 8.3.3 Europe Immune Cell Storage Service Market Share by Application (2021-2032)
- 8.4 Europe Immune Cell Storage Service Market Size by Country
- 8.4.1 Europe Immune Cell Storage Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Immune Cell Storage Service Market Size by Country (2021-2026)
- 8.4.3 Europe Immune Cell Storage Service Market Size by Country (2027-2032)
- 8.4.4 Europe Immune Cell Storage Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Immune Cell Storage Service Market Size (2021-2032)
- 9.2 China Immune Cell Storage Service Market Size by Type
- 9.2.1 China Immune Cell Storage Service Market Size by Type (2021-2026)
- 9.2.2 China Immune Cell Storage Service Market Size by Type (2027-2032)
- 9.2.3 China Immune Cell Storage Service Market Share by Type (2021-2032)
- 9.3 China Immune Cell Storage Service Market Size by Application
- 9.3.1 China Immune Cell Storage Service Market Size by Application (2021-2026)
- 9.3.2 China Immune Cell Storage Service Market Size by Application (2027-2032)
- 9.3.3 China Immune Cell Storage Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Immune Cell Storage Service Market Size (2021-2032)
- 10.2 Asia Immune Cell Storage Service Market Size by Type
- 10.2.1 Asia Immune Cell Storage Service Market Size by Type (2021-2026)
- 10.2.2 Asia Immune Cell Storage Service Market Size by Type (2027-2032)
- 10.2.3 Asia Immune Cell Storage Service Market Share by Type (2021-2032)
- 10.3 Asia Immune Cell Storage Service Market Size by Application
- 10.3.1 Asia Immune Cell Storage Service Market Size by Application (2021-2026)
- 10.3.2 Asia Immune Cell Storage Service Market Size by Application (2027-2032)
- 10.3.3 Asia Immune Cell Storage Service Market Share by Application (2021-2032)
- 10.4 Asia Immune Cell Storage Service Market Size by Country
- 10.4.1 Asia Immune Cell Storage Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Immune Cell Storage Service Market Size by Country (2021-2026)
- 10.4.3 Asia Immune Cell Storage Service Market Size by Country (2027-2032)
- 10.4.4 Asia Immune Cell Storage Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Immune Cell Storage Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Immune Cell Storage Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Immune Cell Storage Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Immune Cell Storage Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Immune Cell Storage Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Immune Cell Storage Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Immune Cell Storage Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Immune Cell Storage Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Immune Cell Storage Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Immune Cell Storage Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Immune Cell Storage Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Immune Cell Storage Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Immune Cell Storage Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Immune Cell Storage Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst